News

ZFGN

Zafgen (ZFGN): Attacking Type 2 Diabetes and Obesity

Edward Kim | Equities.com |

Addressing large addressable markets for metabolic disorders. (Image credit: Diabetes News Journal)


‚ÄčThis Week in Emerging Growth: Fear and Loathing in Cleveland

Joel Anderson | Equities.com |

Markets were up and down but ended up slightly as the nation turned its attention to Cleveland for the Republican National Convention and Dollar Shave Club hit a big payday.


IPO Report: Zafgen (ZFGN)

Francis Gaskins | Equities.com |

Zafgen (ZFGN) is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity. It is headquartered in Cambridge, MA. Eleven other


12 New IPOs Scheduled for Week of June 16

Francis Gaskins | Equities.com |

Complete IPO calendar at IPOpremium.com Ordered by size of IPO. 1. Markit Ltd. ($MRKT) Based in New York, NY, Markit Ltd. scheduled a $1.1 billion IPO on the Nasdaq with a market



Discover: Trending Events

United Nations
Blockchain for Europe
Humanity 2.0
World Economic Forum